CardioGenics Holdings Inc. (OTCMKTS:CGNH – Get Free Report)’s stock price crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $0.00 and traded as high as $0.0001. CardioGenics shares last traded at $0.0001, with a volume of 198,200 shares trading hands.
CardioGenics Price Performance
About CardioGenics
CardioGenics Holdings Inc engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally. Its products include QL Care Analyzer, a portable, stand-alone, and automated point-of-care (POC) immunoassay analyzer that uses a proprietary self-metering cartridge to perform immunoassay tests at the POC; a series of immunoassay tests to identify cardiac markers in the blood at the time of a heart attack; and paramagnetic beads that are used as solid surfaces in heterogeneous immunoassay tests by clinical and research laboratories.
Featured Articles
- Five stocks we like better than CardioGenics
- Investing In Preferred Stock vs. Common Stock
- Up Over 20% in 2025, These 3 Stocks Are Boosting Buyback Capacity
- Stock Splits, Do They Really Impact Investors?
- Congress Beat the Market Again—Here Are the 3 Stocks They Bought
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Go on a Shopping Spree With 3 Top Retail ETFs
Receive News & Ratings for CardioGenics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CardioGenics and related companies with MarketBeat.com's FREE daily email newsletter.
